Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment

BACKGROUND: Recent studies demonstrate that in addition to its modulatory effect on APP processing, in vivo application of Liver X Receptor agonist T0901317 (T0) to APP transgenic and non-transgenic mice decreases the level of Aβ(42. )Moreover, in young Tg2576 mice T0 completely reversed contextual...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lefterov, Iliya, Bookout, Angie, Wang, Zhu, Staufenbiel, Matthias, Mangelsdorf, David, Koldamova, Radosveta
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2007
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2214725/
https://ncbi.nlm.nih.gov/pubmed/17953774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1326-2-20
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak